Published in J Neurosci on February 10, 2010
Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci (2010) 3.47
Neurotransmitter corelease: mechanism and physiological role. Annu Rev Physiol (2011) 1.52
Raphe serotonin neurons are not homogenous: electrophysiological, morphological and neurochemical evidence. Neuropharmacology (2011) 1.30
Activity-dependent neurotransmitter respecification. Nat Rev Neurosci (2012) 1.27
Probing the diversity of serotonin neurons. Philos Trans R Soc Lond B Biol Sci (2012) 1.14
Vesicular and plasma membrane transporters for neurotransmitters. Cold Spring Harb Perspect Biol (2012) 1.02
Glutamatergic drive of the dorsal raphe nucleus. J Chem Neuroanat (2011) 0.93
The multilingual nature of dopamine neurons. Prog Brain Res (2014) 0.93
Dorsal raphe serotonin neurons in mice: immature hyperexcitability transitions to adult state during first three postnatal weeks suggesting sensitive period for environmental perturbation. J Neurosci (2014) 0.90
Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle. Neuroscience (2011) 0.89
Dual-transmitter neurons: functional implications of co-release and co-transmission. Curr Opin Neurobiol (2014) 0.88
Lack of serotonin reuptake during brain development alters rostral raphe-prefrontal network formation. Front Cell Neurosci (2013) 0.88
Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks. Front Physiol (2012) 0.88
Mixed neurotransmission in the hippocampal mossy fibers. Front Cell Neurosci (2013) 0.86
Distribution of VGLUT3 in highly collateralized axons from the rat dorsal raphe nucleus as revealed by single-neuron reconstructions. PLoS One (2014) 0.85
Glutamatergic input is selectively increased in dorsal raphe subfield 5-HT neurons: role of morphology, topography and selective innervation. Eur J Neurosci (2011) 0.85
Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis. Hum Mol Genet (2010) 0.84
Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe. Proc Natl Acad Sci U S A (2013) 0.83
The ascending median raphe projections are mainly glutamatergic in the mouse forebrain. Brain Struct Funct (2014) 0.83
Modulation of firing and synaptic transmission of serotonergic neurons by intrinsic G protein-coupled receptors and ion channels. Front Integr Neurosci (2013) 0.82
Neurotransmitter phenotype plasticity: an unexpected mechanism in the toolbox of network activity homeostasis. Dev Neurobiol (2012) 0.82
Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia. Parkinsons Dis (2011) 0.82
VGLUT3 does not synergize GABA/glycine release during functional refinement of an inhibitory auditory circuit. Front Neural Circuits (2014) 0.81
The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens. Mol Psychiatry (2015) 0.80
Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain. ACS Chem Neurosci (2013) 0.80
Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology. Front Immunol (2016) 0.79
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability. Front Behav Neurosci (2015) 0.78
Brain serotonergic circuitries. Dialogues Clin Neurosci (2010) 0.78
Distribution of vesicular glutamate transporters in the human brain. Front Neuroanat (2015) 0.78
Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease. J Neurosci (2015) 0.77
Co-release of glutamate and GABA from single vesicles in GABAergic neurons exogenously expressing VGLUT3. Front Synaptic Neurosci (2015) 0.77
Serotonergic systems in the balance: CRHR1 and CRHR2 differentially control stress-induced serotonin synthesis. Psychoneuroendocrinology (2015) 0.76
Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum. Basal Ganglia (2012) 0.76
Co-existence of Functionally Different Vesicular Neurotransmitter Transporters. Front Synaptic Neurosci (2016) 0.76
The vesicular glutamate transporter VGLUT3 contributes to protection against neonatal hypoxic stress. J Physiol (2012) 0.76
Axonal Segregation and Role of the Vesicular Glutamate Transporter VGLUT3 in Serotonin Neurons. Front Neuroanat (2016) 0.76
Selective Localization of Shanks to VGLUT1-Positive Excitatory Synapses in the Mouse Hippocampus. Front Cell Neurosci (2016) 0.75
Divergent in vivo activity of non-serotonergic and serotonergic VGluT3-neurones in the median raphe region. J Physiol (2016) 0.75
Cellular architecture and transmitter phenotypes of neurons of the mouse median raphe region. Brain Struct Funct (2016) 0.75
Phospholipase C activity increases in cerebrospinal fluid from migraineurs in proportion to the number of comorbid conditions: a case-control study. J Headache Pain (2013) 0.75
Segregation of Acetylcholine and GABA in the Rat Superior Cervical Ganglia: Functional Correlation. Front Cell Neurosci (2016) 0.75
Regulation of the Hippocampal Network by VGLUT3-Positive CCK- GABAergic Basket Cells. Front Cell Neurosci (2017) 0.75
Development of Serotonergic Fibers in the Post-Natal Mouse Brain. Front Cell Neurosci (2017) 0.75
Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression. Sci Signal (2017) 0.75
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron (2009) 5.20
Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A (2008) 3.74
Amygdala intercalated neurons are required for expression of fear extinction. Nature (2008) 3.37
Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci (2003) 2.85
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron (2010) 2.75
A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci (2002) 2.71
Systemic inflammation disrupts the developmental program of white matter. Ann Neurol (2011) 2.20
Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A (2003) 2.19
A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neurons. Proc Natl Acad Sci U S A (2008) 2.19
Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ Res (2006) 2.10
Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res (2004) 1.92
Phox2b controls the development of peripheral chemoreceptors and afferent visceral pathways. Development (2003) 1.84
Storage and uptake of D-serine into astrocytic synaptic-like vesicles specify gliotransmission. J Neurosci (2013) 1.82
Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation (2006) 1.79
In vivo imaging of intersynaptic vesicle exchange using VGLUT1 Venus knock-in mice. J Neurosci (2011) 1.73
Coherent gamma oscillations couple the amygdala and striatum during learning. Nat Neurosci (2009) 1.69
Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am J Hum Genet (2008) 1.65
Trace but not delay fear conditioning requires attention and the anterior cingulate cortex. Proc Natl Acad Sci U S A (2003) 1.60
The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci (2008) 1.57
Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. J Neurosci (2006) 1.55
Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism. Nat Genet (2009) 1.55
Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway. Nat Neurosci (2010) 1.52
Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev (2008) 1.50
Paradoxical increase in survival of newborn neurons in the dentate gyrus of mice with constitutive depletion of serotonin. Eur J Neurosci (2013) 1.49
Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci U S A (2003) 1.48
Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J Neurosci (2007) 1.48
The SLC36 family: proton-coupled transporters for the absorption of selected amino acids from extracellular and intracellular proteolysis. Pflugers Arch (2003) 1.47
In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI). Magn Reson Med (2003) 1.46
Central amygdala activity during fear conditioning. J Neurosci (2011) 1.44
L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor. J Neurosci (2012) 1.43
GABAergic basket cells expressing cholecystokinin contain vesicular glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and isocortex of the rat. Eur J Neurosci (2004) 1.42
Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation (2005) 1.40
Breathing without CO(2) chemosensitivity in conditional Phox2b mutants. J Neurosci (2011) 1.36
Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation (2003) 1.34
Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest (2003) 1.31
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology (2006) 1.30
Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med (2006) 1.29
Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci (2011) 1.27
The fear circuit revisited: contributions of the basal amygdala nuclei to conditioned fear. J Neurosci (2011) 1.27
The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology (2009) 1.26
Expression of vesicular glutamate transporters in rat lumbar spinal cord, with a note on dorsal root ganglia. J Comp Neurol (2004) 1.25
Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim Biophys Acta (2008) 1.24
Direct Immunohistochemical Evidence of the Existence of 5-HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei. Eur J Neurosci (1990) 1.21
Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy. Proc Natl Acad Sci U S A (2012) 1.19
OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol (2005) 1.18
Functional characterization of wild-type and mutant human sialin. EMBO J (2004) 1.16
Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci (2004) 1.15
Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons. Mol Ther (2005) 1.14
3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol Psychiatry (2007) 1.14
Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. Hum Mol Genet (2004) 1.14
An extended proteome map of the lysosomal membrane reveals novel potential transporters. Mol Cell Proteomics (2013) 1.13
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) (2005) 1.12
Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci (2004) 1.11
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. Br J Pharmacol (2002) 1.10
Distribution and compartmental organization of GABAergic medium-sized spiny neurons in the mouse nucleus accumbens. Front Neural Circuits (2013) 1.09
Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress. Behav Brain Res (2009) 1.08
Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion. Proc Natl Acad Sci U S A (2008) 1.08
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med (2003) 1.08
5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain (2008) 1.07
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A (2011) 1.07
Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci (2004) 1.06
Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem (2008) 1.05
Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol Ther (2007) 1.04
Morphometric characterization of microglial phenotypes in human cerebral cortex. J Neuroinflammation (2014) 1.04
Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology (2011) 1.03
Role of the C-terminal di-leucine motif of 5-HT1A and 5-HT1B serotonin receptors in plasma membrane targeting. J Cell Sci (2006) 1.02
Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiol Dis (2010) 1.02
Beta2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice. J Neurosci (2004) 1.02
Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J Neurosci (2004) 1.02
Impacts of brain serotonin deficiency following Tph2 inactivation on development and raphe neuron serotonergic specification. PLoS One (2012) 1.02
TrkB inhibition as a therapeutic target for CNS-related disorders. Prog Neurobiol (2012) 1.02
Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis (2007) 1.01
Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J Neurosci (2006) 1.01
Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Int J Neuropsychopharmacol (2007) 1.01
Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. Int J Neuropsychopharmacol (2009) 1.01